Petros Pharmaceuticals, Inc. (PTPI) Ownership
PTPI ownership summary
as of October 21, 2026- Institutions
- 10.2% of shares outstanding
- Insiders
- 25.59% of shares outstanding
- Shares outstanding
- 42.4M
- Float
- 28.9M shares available to trade
- Short interest
- 0.77% 12.3M shares short
- Days to cover
- 0.01 short interest up 311.6% vs prior month
- Institutions 10.24%
- Insiders 25.59%
- Other investors 64.18%
PTPI top institutional holders
10 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 0.07% | 36K | $90 | −1,333 (−3.6%) | December 31, 2024 |
| 2 | Vanguard Group Inc | 0.06% | 32K | $80 | — | December 31, 2024 |
| 3 | UBS Group AG | 0.02% | 13K | $32 | −31,229 (−70.6%) | December 31, 2024 |
| 4 | Advisor Group Holdings, Inc. | <0.01% | 200 | $0 | — | December 31, 2024 |
| 5 | Group One Trading, LP | <0.01% | 79 | $0 | — | December 31, 2024 |
| 6 | Bank of America Corp | <0.01% | 75 | $0 | +3 (+4.2%) | December 31, 2024 |
| 7 | Morgan Stanley - Brokerage Accounts | 0.00% | 19 | $0 | — | December 31, 2024 |
| 8 | BlackRock Inc | 0.00% | — | — | −16,128 (−100.0%) | March 31, 2025 |
| 9 | Tower Research Capital LLC | 0.00% | — | — | −3,255 (−100.0%) | December 31, 2024 |
| 10 | TWO SIGMA SECURITIES, LLC | 0.00% | — | — | −32,284 (−100.0%) | December 31, 2024 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 10, 1 holders added 3 shares and 5 cut 84K.
PTPI top mutual fund and ETF holders
15 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.17% | 92K | $230 | +57,158 (+165.0%) | March 31, 2025 |
| 2 | Vanguard Institutional Extnd Mkt Idx Tr | 0.06% | 32K | $80 | — | March 31, 2025 |
| 3 | Fidelity Series Total Market Index | 0.03% | 16K | $41 | +15,216 (+1,311.7%) | March 31, 2025 |
| 4 | Northern Trust Extended Eq Market Idx | <0.01% | 510 | $1 | — | March 31, 2025 |
| 5 | NT Ext Equity Mkt Idx Fd - L | <0.01% | 510 | $1 | — | March 31, 2025 |
| 6 | NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | <0.01% | 122 | $0 | +1 (+0.8%) | March 31, 2025 |
| 7 | NT Ext Eq Mkt Indx Fd DC Lend T4 | <0.01% | 122 | $0 | +122 (0.0%) | December 31, 2024 |
| 8 | NT Ext Eq Mkt Indx Fd DC Lend T3 | <0.01% | 122 | $0 | +122 (0.0%) | December 31, 2024 |
| 9 | NT Ext Equity Mkt Idx Fd - NL | <0.01% | 118 | $0 | — | March 31, 2025 |
| 10 | NT Ext Equity Mkt Idx Fd - DC - NL - T2 | <0.01% | 92 | $0 | −2 (−2.1%) | March 31, 2025 |
| 11 | SSgA U.S. Total Market Index Strategy | <0.01% | 80 | $0 | +2 (+2.6%) | March 31, 2025 |
| 12 | Northern Trust Wilshire 5000 | <0.01% | 52 | $0 | — | March 31, 2025 |
| 13 | NT Quality SCC US Fund - L | <0.01% | 51 | $0 | — | March 31, 2025 |
| 14 | NT Quality Small Cap Core | <0.01% | 51 | $0 | — | March 31, 2025 |
| 15 | Blackstone Alternative Multi-Strategy I | <0.01% | 35 | $0 | +35 (0.0%) | December 31, 2024 |
Funds report holdings monthly or quarterly; dates differ by fund.
PTPI insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2021-11-29 | John D Shulman | Buy | $30.00 | 50,000 | $1.5M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
PTPI shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PTPI
Institutional investors own 10.2% of Petros Pharmaceuticals's shares and insiders 25.59%. The largest holder is Geode Capital Management, LLC with 0.07% of the shares (36K), as of December 31, 2024. Among the top 10 institutions, 1 added shares and 5 reduced their stake in the latest filings. Short interest is 0.77% of the float, or 0.01 days of average trading volume. The share count rose 6,439.5% since 2019.
Related: PTPI analyst forecast, PTPI key metrics. See the PTPI stock overview for the latest quote and news.
PTPI ownership FAQ
Who owns the most Petros Pharmaceuticals stock?
The largest shareholders of Petros Pharmaceuticals are Geode Capital Management, LLC (0.07%), Vanguard Group Inc (0.06%), UBS Group AG (0.02%), Advisor Group Holdings, Inc. (<0.01%), Group One Trading, LP (<0.01%).
What percentage of Petros Pharmaceuticals is owned by institutions?
Institutions hold 10.2% of Petros Pharmaceuticals's shares outstanding; insiders hold 25.59%.
Which funds own Petros Pharmaceuticals?
The largest fund holders of Petros Pharmaceuticals are Fidelity Extended Market Index (0.17%), Vanguard Institutional Extnd Mkt Idx Tr (0.06%), Fidelity Series Total Market Index (0.03%), Northern Trust Extended Eq Market Idx (<0.01%), NT Ext Equity Mkt Idx Fd - L (<0.01%).
What is Petros Pharmaceuticals's short interest?
12.3M shares of Petros Pharmaceuticals were sold short, 0.77% of the float; at the average daily volume it would take 0.01 days to cover.
Are insiders buying or selling Petros Pharmaceuticals?
Of the latest 1 reported insider transactions in Petros Pharmaceuticals (since November 29, 2021), 1 were purchases and 0 were sales.
How many shares of Petros Pharmaceuticals are outstanding?
Petros Pharmaceuticals has 42.4M shares outstanding, of which 28.9M are in the public float.